Follicular lymphoma grade II, intrapelvic lymph nodes
ICD-10 C82.16 is a billable code used to indicate a diagnosis of follicular lymphoma grade ii, intrapelvic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade II indicates an intermediate level of aggressiveness, with a higher number of centroblasts compared to grade I. In this case, the lymphoma is specifically located in the intrapelvic lymph nodes, which can include nodes in the iliac, inguinal, or pelvic regions. Patients may present with B-symptoms such as fever, night sweats, and unexplained weight loss, which can indicate a more advanced disease state. Diagnosis typically involves imaging studies such as CT scans or PET scans, along with biopsy of affected lymph nodes. Treatment protocols often include watchful waiting for asymptomatic patients, followed by chemotherapy, immunotherapy, or radiation therapy for symptomatic cases. The prognosis varies based on the stage at diagnosis and response to treatment, with a focus on managing symptoms and improving quality of life.
Detailed clinical notes on symptoms, staging, and treatment plans.
Diagnosis and management of newly diagnosed follicular lymphoma, treatment response evaluations.
Ensure accurate grading and staging are documented to support coding.
Imaging reports detailing lymph node involvement and any changes over time.
Imaging for staging and follow-up of lymphoma treatment.
Clear documentation of imaging findings related to lymph node locations is crucial.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy administration.
Common treatment options include watchful waiting for asymptomatic patients, chemotherapy regimens such as R-CHOP, immunotherapy with monoclonal antibodies, and radiation therapy for localized disease.
